No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs553398415 |
chr17:46504490-46504491 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs9900511 |
chr17:46504524-46504525 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
3 |
rs150849910 |
chr17:46504530-46504531 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs570879603 |
chr17:46504551-46504552 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs79496389 |
chr17:46504581-46504582 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs574834409 |
chr17:46504590-46504591 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs111380436 |
chr17:46504615-46504616 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs534969545 |
chr17:46504616-46504617 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs553635322 |
chr17:46504651-46504652 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs138710979 |
chr17:46504703-46504704 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs180989146 |
chr17:46504775-46504776 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs149557871 |
chr17:46504791-46504792 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs552011545 |
chr17:46504805-46504806 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs559355270 |
chr17:46504819-46504820 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs574886368 |
chr17:46504843-46504844 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs536042906 |
chr17:46504851-46504852 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs548803522 |
chr17:46504854-46504855 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs556590464 |
chr17:46504856-46504857 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs537372907 |
chr17:46504874-46504875 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs185755925 |
chr17:46504897-46504898 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs550843372 |
chr17:46504936-46504937 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs570527008 |
chr17:46504952-46504953 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs373771017 |
chr17:46504971-46504972 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs539791808 |
chr17:46504977-46504978 |
Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs553193367 |
chr17:46505001-46505002 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs112984686 |
chr17:46505018-46505019 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs559144009 |
chr17:46505021-46505022 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs114239124 |
chr17:46505053-46505054 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs554833523 |
chr17:46505056-46505057 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs80112766 |
chr17:46505105-46505106 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs144156399 |
chr17:46505191-46505192 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs557267467 |
chr17:46505325-46505326 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs372183263 |
chr17:46505370-46505371 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs576913787 |
chr17:46505371-46505372 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs545744937 |
chr17:46505384-46505385 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs368772392 |
chr17:46505389-46505390 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs373845380 |
chr17:46505396-46505397 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs528234530 |
chr17:46505464-46505465 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs140580572 |
chr17:46505561-46505562 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs561975893 |
chr17:46505645-46505646 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs77463459 |
chr17:46505687-46505688 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs7211712 |
chr17:46505696-46505697 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
43 |
rs371975219 |
chr17:46505709-46505710 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs142806741 |
chr17:46505714-46505715 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs182291502 |
chr17:46505716-46505717 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs547011659 |
chr17:46505721-46505722 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs375562690 |
chr17:46505724-46505725 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs566732501 |
chr17:46505867-46505868 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs147393881 |
chr17:46505996-46505997 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs369777089 |
chr17:46506013-46506014 |
Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|